Concepedia
Statistics
Publications
28
Citations
6.7K
H-Index
23
Active since
1994
Affiliations
Biogen (United States)(Current)
Vertex Pharmaceuticals (United States)
Cleveland Clinic
Georgetown University
University of Colorado Health
John Alam is an author at Biogen (United States) specializing in pharmacology, medicine, and antiviral therapy.
Publications per year
1994–2023
Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis
Diane L. Cookfair, Richard A. Rudick, Robert M. Herndon et al. · Annals of Neurology · 1996 · 2.4K citations
Pharmacy, Neurology, Pharmacotherapy +12
Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
John G. McHutchison, Gregory T. Everson, Stuart C. Gordon et al. · New England Journal of Medicine · 2009 · 1.1K citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +12
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
Christophe Hézode, Nicole Forestier, Geoffrey Dusheiko et al. · New England Journal of Medicine · 2009 · 1K citations
Rapid Decline of Viral RNA in Hepatitis C Patients Treated With VX-950: A Phase Ib, Placebo-Controlled, Randomized Study
Hendrik W. Reesink, Stefan Zeuzem, Christine J. Weegink et al. · Gastroenterology · 2006 · 396 citations
Pharmacy, Infectious Diseases, Pharmacotherapy +13
Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis
Jack H. Simon, Marilyn Campion, Karl Wende et al. · Annals of Neurology · 1998 · 334 citations · Full text
Life Sciences, Internal Medicine, Neurology +13
1–5 of 28